gs3 -05: "fulvestrant-palbociclib vs continuing aromatase inhibitor-palbociclib upon detection..."
Published 1 year ago • 48 plays • Length 15:53Download video MP4
Download video MP3
Similar videos
-
2:56
parsifal-long: fulvestrant and palbociclib vs letrozole and palbociclib
-
10:05
gs2-05: "randomized comparison of adjuvant aromatase inhibitor exemestane (e) plus ovarian..."
-
0:55
fulvestrant plus palbociclib in breast cancer
-
2:02
palbociclib combined with fulvestrant in relapsed metastatic hr /her2- breast cancer
-
0:59
ribociclib in adjuvant hr breast cancer
-
22:49
highlights of the 2023 san antonio breast cancer symposium with jason mouabbi, md
-
14:31
p-reality-x: real-world, overall survival with palbociclib aromatase inhibitor in hr /her2- mbc
-
5:04
paloma-3: palbociclib and fulvestrant for hr-/her metastatic breast cancer
-
1:29
capitello-292: capivasertib, palbociclib, and fulvestrant for hr endocrine-resistant breast cancer
-
13:22
palbociclib and breast cancer
-
1:05
dr. verma on palbociclib plus fulvestrant for hr /her2- breast cancer
-
1:13
dr. pagani discusses aromatase inhibitors for premenopausal women with breast cancer
-
0:52
first-line camizestrant for er /her2- advanced breast cancer
-
1:49
phase ib data capitello-292: capivasertib palbociclib fulvestrant in hr /her2- breast cancer
-
3:46
harmonia clinical trial
-
0:20
cutting the risk of breast cancer
-
5:10
paloma-3: overall survival (os) with palbociclib plus fulvestrant in hr ,her2_ abc
-
2:45
paloma-3: phase 3 trial of fulvestrant with palbociclib for metastatic breast cancer